Cigna oncology value-based pathways

Cigna oncology value-based pathways program was created to promote the use of evidence-based, high value, cancer treatment regimens. Pathway regimens are a subset of regimens recommended by the National Comprehensive Cancer Network® (NCCN) that deliver the best clinical outcomes for patients.

Anal Cancer Pathways:

Biliary Tract Cancers (Gallbladder/Cholangiocarcinoma) Pathways:

Bladder Cancer Pathways:

Breast Cancer Pathways:

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Pathways:

Chronic Myeloid Leukemia Pathways:

Colon Cancer Pathways:

Diffuse Large B-cell Lymphoma Pathways:

Endometrial Cancer Pathways:

Esophageal and Esophagogastric Junction Cancer Pathways:

Follicular B-cell Lymphoma Pathways:

Head and Neck Cancer Pathways:

Hepatocellular Carcinoma Pathways:

Hodgkin’s Lymphoma Pathways:

Kidney Cancer Pathways:

Lung Cancer: Non-small Cell Lung Cancer Pathways:

Lung Cancer: Small Cell Lung Cancer Pathways:

Melanoma Pathways:

Multiple Myeloma Pathways:

Myelodysplastic Syndrome (MDS) Pathways:

Neuroendocrine Cancer Pathways:

Ovarian Cancer Pathways:

Pancreatic Cancer Pathways:

Testicular Cancer Pathways: